Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 11 studies | 34% ± 21% | |
| interneuron | 4 studies | 42% ± 17% | |
| adipocyte | 4 studies | 22% ± 3% | |
| glutamatergic neuron | 4 studies | 42% ± 14% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 4% | |
| smooth muscle cell | 4 studies | 21% ± 3% | |
| endothelial cell | 3 studies | 31% ± 7% | |
| hepatocyte | 3 studies | 69% ± 19% | |
| GABAergic neuron | 3 studies | 53% ± 12% | |
| ependymal cell | 3 studies | 29% ± 13% | |
| fibroblast | 3 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 474.19 | 225 / 226 | 98% | 17.95 | 396 / 406 |
| kidney | 100% | 748.22 | 89 / 89 | 87% | 14.73 | 786 / 901 |
| breast | 89% | 112.37 | 409 / 459 | 90% | 7.28 | 1006 / 1118 |
| uterus | 97% | 157.85 | 165 / 170 | 76% | 6.28 | 349 / 459 |
| ovary | 100% | 220.63 | 180 / 180 | 71% | 4.89 | 306 / 430 |
| brain | 64% | 71.74 | 1704 / 2642 | 96% | 5.14 | 678 / 705 |
| skin | 64% | 342.27 | 1161 / 1809 | 89% | 7.58 | 421 / 472 |
| thymus | 81% | 88.09 | 531 / 653 | 70% | 4.01 | 421 / 605 |
| intestine | 94% | 194.20 | 910 / 966 | 51% | 2.73 | 270 / 527 |
| prostate | 79% | 92.22 | 193 / 245 | 65% | 3.43 | 324 / 502 |
| bladder | 86% | 166.33 | 18 / 21 | 56% | 4.63 | 283 / 504 |
| adrenal gland | 100% | 1573.91 | 258 / 258 | 42% | 2.66 | 96 / 230 |
| esophagus | 84% | 242.22 | 1207 / 1445 | 52% | 4.02 | 95 / 183 |
| lung | 30% | 28.47 | 176 / 578 | 73% | 5.58 | 839 / 1155 |
| pancreas | 14% | 11.18 | 45 / 328 | 87% | 12.25 | 155 / 178 |
| blood vessel | 100% | 1057.14 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 203.27 | 784 / 803 | 0% | 0 | 0 / 0 |
| stomach | 36% | 45.33 | 130 / 359 | 56% | 2.59 | 161 / 286 |
| heart | 85% | 143.48 | 731 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 6.50 | 38 / 45 |
| adipose | 75% | 88.32 | 904 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 50% | 50.81 | 120 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 46% | 2.10 | 37 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 4.31 | 4 / 29 |
| peripheral blood | 1% | 0.87 | 6 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0047369 | Molecular function | succinate-hydroxymethylglutarate CoA-transferase activity |
| Gene name | SUGCT |
| Protein name | Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase) Succinyl-CoA:glutarate-CoA transferase |
| Synonyms | C7orf10 DERP13 |
| Description | FUNCTION: Catalyzes the succinyl-CoA-dependent conversion of glutarate to glutaryl-CoA. Can use different dicarboxylic acids as CoA acceptors, the preferred ones are glutarate, succinate, adipate, and 3-hydroxymethylglutarate. . |
| Accessions | ENST00000401647.7 [Q9HAC7-4] H0Y4N1 ENST00000628514.3 [Q9HAC7-3] ENST00000413931.6 H7C1N0 H7C0H3 Q9HAC7 ENST00000444074.3 ENST00000335693.9 [Q9HAC7-1] ENST00000416370.2 |
